These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1718058)

  • 1. Effect of recombinant human granulocyte colony-stimulating factor (rhG-CSF) on allogeneic bone marrow transplantation in mice.
    Fukuhara N; Ohnishi N; Mori T; Ozawa A
    Tokai J Exp Clin Med; 1990 May; 15(2-3):261-2. PubMed ID: 1718058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of recombinant human granulocyte colony stimulating factor (rhG-CSF) on hemopoiesis and survival rate following allogeneic bone marrow transplantation in mice.
    Fukuhara N; Ohnishi N; Ozawa A; Mori T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1992 Nov; 52(11):1589-98. PubMed ID: 1281539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of recombinant human granulocyte colony-stimulating factor on the mice receiving bone marrow transplantation following lethal irradiation: acceleration of recovery of the peripheral blood neutrophils and potentiation of anti-Pseudomonas resistance.
    Tamura M; Matsumoto M; Yoshino T; Matsubara S; Imai N; Ono M; Yokota T
    Exp Hematol; 1991 Jan; 19(1):18-23. PubMed ID: 1703491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A synergistic increase in transplantable peripheral blood stem cells in mice by co-administration of recombinant human interleukin 6 and recombinant human granulocyte colony-stimulating factor.
    Suzuki H; Okano A; Suzuki C; Konishi A; Akiyama Y; Ishibashi T; Ozawa K; Asano S
    Transplantation; 1995 Jun; 59(11):1596-600. PubMed ID: 7539959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance of donors treatment with combination of recombinant human interleukin-11 and recombinant human granulocyte-colony stimulating factor in reduction of incidence of lethal grafts versus host disease after allogeneic bone marrow transplantation].
    Zhao J; Zhao XY; Huang XJ
    Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(35):2497-502. PubMed ID: 16321278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical effects of recombinant human granulocyte colony-stimulating factor in leukemia patients: a phase I/II study.
    Teshima H; Ishikawa J; Kitayama H; Yamagami T; Hiraoka A; Nakamura H; Shibata H; Masaoka T; Takaku F
    Exp Hematol; 1989 Sep; 17(8):853-8. PubMed ID: 2475358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxis.
    Martin-Algarra S; Bishop MR; Tarantolo S; Cowles MK; Reed E; Anderson JR; Vose JM; Bierman P; Armitage JO; Kessinger A
    Exp Hematol; 1995 Dec; 23(14):1503-8. PubMed ID: 8542938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human glycosylated granulocyte colony-stimulating factor (rhG-CSF)-combined regimen for allogeneic bone marrow transplantation in refractory acute myeloid leukemia.
    Takahashi S; Okamoto SI; Shirafuji N; Ikebuchi K; Tani K; Shimane M; Matsudaira T; Irie S; Tsuruta T; Matsuishi E
    Bone Marrow Transplant; 1994 Mar; 13(3):239-45. PubMed ID: 7515298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human granulocyte colony-stimulating factor improves the compromised state of recipient mice without affecting the induction of specific tolerance in the cyclophosphamide-induced tolerance system.
    Nishimura Y; Mayumi H; Tomita Y; Eto M; Maeda T; Nomoto K
    J Immunol; 1991 Apr; 146(8):2639-47. PubMed ID: 1707914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating donor mice with rhIL-11 and rhG-CSF promotes transplant-tolerance and preserves the effects of GVL after allogeneic bone marrow transplantation.
    Huang XJ; Zhao J; Zhao XY; Chang YJ
    Leuk Res; 2009 Jan; 33(1):123-8. PubMed ID: 18653235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulocyte kinetics in neutrophilia induced by recombinant human granulocyte colony-stimulating factor in mice.
    Yamagiwa A
    Fukushima J Med Sci; 1991 Jun; 37(1):1-11. PubMed ID: 1725671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematopoietic progenitor cell mobilization into the peripheral blood of mice using a combination of recombinant rat stem cell factor (rrSCF) and recombinant human granulocyte colony-stimulating factor (rhG-CSF).
    Drize N; Chertkov J; Zander A
    Exp Hematol; 1995 Oct; 23(11):1180-6. PubMed ID: 7556528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of endogenous and exogenous granulocyte colony-stimulating factor after autologous blood stem cell transplantation.
    Shimazaki C; Uchiyama H; Fujita N; Araki S; Sudo Y; Yamagata N; Ashihara E; Goto H; Inaba T; Haruyama H
    Exp Hematol; 1995 Dec; 23(14):1497-502. PubMed ID: 8542937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical effect of recombinant human granulocyte colony-stimulating factor in bone marrow transplantation. The Japan rhG-CSF Clinical Study Group].
    Asano S; Masaoka T; Takaku F
    Gan To Kagaku Ryoho; 1990 Jun; 17(6):1201-9. PubMed ID: 1693489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic effects of granulocyte-colony stimulating factor and macrophage-colony stimulating factor on recovery of donor hematopoietic cells in allogeneic bone marrow transplantation.
    Zhang Y; Adachi Y; Suzuki Y; Minamino K; Iwasaki M; Nakano K; Koike Y; Mukaide H; Shigematsu A; Kiriyama N; Li C; Ikehara S
    Oncol Rep; 2006 Aug; 16(2):367-71. PubMed ID: 16820917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of cytokine treatment (granulocyte colony-stimulating factor and stem cell factor) on hematopoiesis and the circulating pool of hematopoietic stem cells in mice.
    Drize N; Chertkov J; Samoilina N; Zander A
    Exp Hematol; 1996 Jun; 24(7):816-22. PubMed ID: 8647232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of recombinant human granulocyte colony-stimulating factor in children given allogeneic bone marrow transplantation for acute or chronic leukemia.
    Locatelli F; Pession A; Zecca M; Bonetti F; Prete L; Carrà AM; Prete A; Montagna D; Comoli P; Taibi RM; Paolucci G
    Bone Marrow Transplant; 1996 Jan; 17(1):31-7. PubMed ID: 8673051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of recombinant granulocyte colony-stimulating factor (rG-CSF) and recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF) on acute radiation hematopoietic injury in mice.
    Tanikawa S; Nakao I; Tsuneoka K; Nara N
    Exp Hematol; 1989 Sep; 17(8):883-8. PubMed ID: 2475360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different response to recombinant human granulocyte-macrophage colony-stimulating factor in primary and secondary graft failure after bone marrow transplantation.
    Sierra J; Terol MJ; Urbano-Ispizua A; Rovira M; Marin P; Carreras E; Batlle M; Rozman C
    Exp Hematol; 1994 Jul; 22(7):566-72. PubMed ID: 8013572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.